Skip to content

SG Blocks (SGBX) Stock Skyrockets 105% – Plans To Build LAX COVID-19 Test Centres

Updated 25 Sep 2020
SGBX Stock

Shares of New York-based SG Blocks (NASDAQ: SGBX) have skyrocketed after the company announced plans to build coronavirus testing centres for Los Angeles International Airport with architecture and design firm Grimshaw.

new-recommended-broker-banner

The centres are expected to be delivered on the 1st of November 2020 with D-Tec 2 model testing pods that feature a CLIA certified laboratory and offer OSANG GeneFinder tests that can provide results in two hours.

“Accessible and rapid testing are essential in our world today and through our turnkey D-Tec Testing Pods, we are pleased to be able to offer both,” said Paul Galvin, Chairman and CEO of SG Blocks.

The GeneFinder test is produced by OSANG Healthcare, a South Korea based medical grade tests and equipment manufacturer. Earlier this year SG Blocks signed a one-year deal with OSANG for its GeneFinder COVID-19 test in the US.

SG Blocks shares…

SG Blocks share price skyrocketed after the news was announced. The company’s share price closed Thursday’s session at $1.52 per share and is currently up 105% at $3.15 premarket on Friday.

PEOPLE WHO READ THIS ALSO VIEWED: